ElectroCore CFO Buys 45,000 Shares Amid Anticipated Vagus‑Nerve Therapy Rollout【Flash】
ElectroCore CFO buys 45k shares, boosting insider confidence amid new patents and neuro‑modulation breakthroughs—investors see a potential upside.
3 minutes to read

